Canlyniadau Chwilio - Courèche Kaderbhaï

  • Dangos 1 - 5 canlyniadau o 5
Mireinio'r Canlyniadau
  1. 1
    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer

    The Role of Molecular Profiling to Predict the Response to Immune Checkpoint Inhibitors in Lung Cancer gan Courèche Kaderbhaï, Zoé Tharin, François Ghiringhelli

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies

    Targeting Immune Checkpoint Inhibitors for Non-Small-Cell Lung Cancer: Beyond PD-1/PD-L1 Monoclonal Antibodies gan Nicolas Roussot, Courèche Kaderbhaï, François Ghiringhelli

    Cyhoeddwyd 2025
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Antibiotic Use Does Not Appear to Influence Response to Nivolumab

    Antibiotic Use Does Not Appear to Influence Response to Nivolumab gan Courèche Kaderbhaï, Corentin Richard, Jean David Fumet, Anne Aarnink, Pascal Foucher, Bruno Coudert, Laure Favier, Aurélie Lagrange, Emeric Limagne, Romain Boidot, François Ghiringhelli

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma

    Blood baseline neutrophil count predicts bevacizumab efficacy in glioblastoma gan Aurélie Bertaut, Caroline Truntzer, Rachid Madkouri, Courèche Kaderbhaï, Valentin Dérangère, Julie Vincent, Bruno Chauffert, Marie Hélène Aubriot-Lorton, Wahlid Farah, Klaus Luc Mourier, Romain Boidot, François Ghiringhelli

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer

    Clinical Utility of Genomic Tests Evaluating Homologous Recombination Repair Deficiency (HRD) for Treatment Decisions in Early and Metastatic Breast Cancer gan Loïck Galland, Nicolas Roussot, Isabelle Desmoulins, Didier Mayeur, Courèche Kaderbhaï, Silvia Ilie, Audrey Hennequin, Manon Réda, Juliette Albuisson, Laurent Arnould, Romain Boidot, Caroline Truntzer, François Ghiringhelli, Sylvain Ladoire

    Cyhoeddwyd 2023
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: